Xenetic Biosciences, Inc.

US$1.87As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:XBIOHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (43.31%)
Div yield —
ROE (47.04%)
Biotechnology
Beta (5Y) 2.35
PE TTM —
TSR TTM (43.99%)
Mkt cap US$4.384M
ROIC (31.38%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$2.39
27.57%
(66.27%)
Hold 5|11|11|6|1
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.05
0.05
0.05
0.05
24.17%
27.27%
14.01%
10.63%
Revenue$M
0.219
0.232
0.231
0.229
(0.70%)
6.40%
6.35%
6.47%
Peers (US$4.383M)
Cap (US$)
PE
4.439M
—
4.354M
—
Capital
TTM
5Y
10Y
Leveragex
1.388
(0.025)
(0.022)
EBIT/Intx
3.243
0.536
0.460
Own earn%
59.10
10.67
12.73
Sh yield%
32.74
41.33
41.65
Owners
Insiders/Inst%
8.13
36.30
Short interest%
2.79
SBC / revenue%
0.96
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
11
Op margin range%
13–19
$1 testx
—
Incr. ROIC%
52